Nafiseh Erfanian

Nafiseh Erfanian

Auto-generated profile, based on publicly available information

Nafiseh Erfanian

Cellular and Molecular Research Center, Birjand University of Medical Sciences, Birjand, Iran

Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
3 March 2024 in Heliyon
Verified
Journal Article
Open access
HSHossein Safarpour
Hossein Safarpour
JRJavad Ranjbaran
Javad Ranjbaran
NENafiseh Erfanian
Nafiseh Erfanian
SNSamira Nomiri
Samira Nomiri
ADAfshin Derakhshani
Afshin Derakhshani
Nicola SilvestrisNicola Silvestris
Nicola Silvestris
Colorectal cancer (CRC) ranks among the most widespread malignancies globally, with early detection significantly influencing prognosis. Employing a systems biology approach, we aimed to unravel the intricate mRNA-miRNA network linked to CRC pathogenesis, potentially yielding diagnostic biomarkers. Through an integrative analysis of microarray, Bulk RNA-seq, and single-cell RNA-seq data, we explored CRC-related transcriptomes comprehensively. Differential gene expression analysis uncovered crucial genes, while Weighted Gene Co-expression Network Analysis (WGCNA) identified key modules closely linked to CRC. Remarkably, CRC manifested its strongest correlation with the turquoise module, signifying its pivotal role. From the cohort of genes showing high Gene Significance (GS) and Module Membership (MM), and Differential Expression Genes (DEGs), we highlighted the downregulated Chromogranin A (CHGA) as a notable hub gene in CRC. This finding was corroborated by the Human Protein Atlas database, which illustrated decreased CHGA expression in CRC tissues. Additionally, CHGA displayed elevated expression in primary versus metastatic cell lines, as evidenced by the CCLE database. Subsequent RT-qPCR validation substantiated the marked downregulation of CHGA in CRC tissues, reinforcing the significance of our differential expression analysis. Analyzing the Space-Time Gut Cell Atlas dataset underscored specific CHGA expression in epithelial cell subclusters, a trend persisting across developmental stages. Furthermore, our scrutiny of colon and small intestine Enteroendocrine cells uncovered distinct CHGA expression patterns, accentuating its role in CRC pathogenesis. Utilizing the WGCNA algorithm and TargetScan database, we validated the downregulation of hsa-miR-137 in CRC, and integrated assessment highlighted its interplay with CHGA. Our findings advocate hsa-miR-137 and CHGA as promising CRC biomarkers, offering valuable insights into diagnosis and prognosis. Despite proteomic analysis yielding no direct correlation, our multifaceted approach contributes comprehensive understanding of CRC's intricate regulatory mechanisms. In conclusion, this study advances hsa-miR-137 and CHGA as promising CRC biomarkers through an integrated analysis of diverse datasets and network interactions.

27 November 2021 in bioRxiv
Verified
Preprint
Open access
PDF file
NENafiseh Erfanian
Nafiseh Erfanian
AHA. Ali Heydari
A. Ali Heydari
PIPablo Iañez
Pablo Iañez
ADAfshin Derakhshani
Afshin Derakhshani
MGMohammad Ghasemigol
Mohammad Ghasemigol
Amirhossein SahebkarAmirhossein Sahebkar
Amirhossein Sahebkar
Traditional bulk sequencing methods are limited to measuring the average signal in a group of cells, potentially masking heterogeneity, and rare populations. The single-cell resolution, however, enhances our understanding of complex biological systems and diseases, such as cancer, the immune system, and chronic diseases. However, the single-cell technologies generate massive amounts of data that are often high-dimensional, sparse, and complex, thus making analysis with traditional computational approaches difficult and unfeasible. To tackle these challenges, many are turning to deep learning (DL) methods as potential alternatives to the conventional machine learning (ML) algorithms for single-cell studies. DL is a branch of ML capable of extracting high-level features from raw inputs in multiple stages. Compared to traditional ML, DL models have provided significant improvements across many domains and applications. In this work, we examine DL applications in genomics, transcriptomics, spatial transcriptomics, and multi-omics integration, and address whether DL techniques will prove to be advantageous or if the single-cell omics domain poses unique challenges. Through a systematic literature review, we find that DL has not yet revolutionized or addressed the most pressing challenges of the single-cell omics field. However, using DL models for single-cell omics has shown promising results (in many cases outperforming the previous state-of-the-art models) in data preprocessing and downstream analysis, but many DL models still lack the needed biological interpretability. Although developments of DL algorithms for single-cell omics have generally been gradual, recent advances reveal that DL can offer valuable resources in fast-tracking and advancing research in single-cell.Abstract Figure:

1 January 2025 in Dermatology Research and Practice
Verified
Journal Article
Open access
SKSomaye Karimi
Somaye Karimi
NFNarges Fallahi
Narges Fallahi
SHSeyedeh Sindokht Hosseini
Seyedeh Sindokht Hosseini
MFMohammad Fereidouni
Mohammad Fereidouni
FGFahime Ghasemi
Fahime Ghasemi
MRMitra Rafiee
Mitra Rafiee
Introduction: Psoriasis, as a common inflammatory skin disease, is characterized by hyperproliferation of epidermal keratinocytes and induction of an inflammatory response. Apoptosis induction and prevention of the proliferation of keratinocytes can help to treat and manage this disease. Thymoquinone (TQ), a bioactive compound with antioxidant and anti‐inflammatory properties, has also been reported as a natural antitumor agent. This study aimed to evaluate the effects of TQ on proliferation and apoptosis in human keratinocyte cells (HaCaT). Methods: HaCaT cells were treated with increasing concentrations of TQ (1, 2, 4, 6, 8, 16, 32, and 64 μg/mL), and cell viability was assessed using the MTT assay. Apoptosis was analyzed via flow cytometry using Annexin V‐FITC/PI staining. Expression levels of p53, Bax, and BCL‐xl genes were measured by real‐time PCR. Results: TQ significantly reduced cell viability in a dose‐dependent manner, with an IC50 of 11.64 μg/mL after 72 h. Flow cytometry revealed a marked increase in early apoptotic cells following treatment with 8 μg/mL TQ (41.00% ± 5.04%) compared to control (17.8% ± 2.26%, P ≤ 0.001). Gene expression analysis showed significant upregulation of p53, while Bax and BCL‐xl levels showed no significant changes. Conclusion: TQ induces apoptosis in human HaCaT cells primarily through p53‐dependent pathways, suggesting its potential as a therapeutic agent for skin‐related disorders .

1 September 2026 in Microbiologyopen
Verified
Journal Article
Open access
MMMohammad Ali Mahdiabadi
Mohammad Ali Mahdiabadi
AMAsma Moghaddam
Asma Moghaddam
NENafiseh Erfanian
Nafiseh Erfanian
Inflammatory bowel disease (IBD) is characterized by chronic intestinal inflammation and compromised epithelial barrier integrity. Emerging evidence demonstrates that gut microbiota‐derived tryptophan metabolites serve as endogenous ligands for the aryl hydrocarbon receptor (AhR), initiating protective signaling cascades that restore mucosal homeostasis. This review synthesizes current mechanistic insights into how microbial tryptophan catabolites including indole‐3‐aldehyde, indole‐3‐propionic acid, indole‐3‐lactic acid, and indole‐3‐acetic acid activate AhR to enhance epithelial barrier function. However, this protective capacity is specific to activation by physiological, low‐affinity microbial ligands and should not be generalized to AhR signaling irrespective of ligand identity, dose, or duration of exposure. Key bacterial producers include Lactobacillus species ( L. reuteri and L. plantarum ), Clostridium sporogenes , and Allobaculum species. AhR activation by these metabolites triggers multiple downstream pathways, including AMP‐activated protein kinase (AMPK) activation, which promotes autophagy and mitochondrial homeostasis; nuclear factor erythroid 2‐related factor 2 (Nrf2)‐mediated antioxidant responses; nuclear factor‐κB (NF‐κB) inhibition, which reduces pro‐inflammatory cytokine production; and interleukin‐22 (IL‐22) induction, which supports epithelial regeneration. These signaling events converge to upregulate tight junction proteins, preserve mucus layer integrity, and reduce actomyosin‐mediated permeability through decreased myosin light chain phosphorylation. Preclinical studies demonstrate AhR‐dependent barrier restoration, with protective effects abolished by AhR antagonists. Despite these preclinical findings, their therapeutic utility in IBD remains to be established in human interventional studies. Importantly, the protective effects of AhR are highly context‐dependent, as kynurenine pathway ligands and sustained receptor activation may exert immunosuppressive or pro‐tumorigenic effects, highlighting the importance of ligand selectivity in therapeutic development.

17 April 2026 in Cellular and Molecular Neurobiology
Verified
Journal Article
Open access
PDF file
PNParsa Navazi
Parsa Navazi
MFMohammad Fereidouni
Mohammad Fereidouni
NENafiseh Erfanian
Nafiseh Erfanian
Multiple sclerosis (MS) is a chronic immune-mediated disorder of the central nervous system. In this disease, mitochondrial dysfunction contributes to neurodegeneration, axonal loss, and progressive disability. Extracellular vesicle (EV)-mediated mitochondrial transfer has emerged as a promising cell-free strategy to restore mitochondrial homeostasis and modulate immune responses within the CNS. Preclinical studies, particularly in experimental autoimmune encephalomyelitis models, demonstrate that EV-based delivery of mitochondrial cargo improves cellular bioenergetics. In parallel, this approach reduces oxidative stress and neuroinflammation while supporting remyelination and neuroprotection. This review summarizes the mechanistic rationale, current preclinical evidence, and future translational perspectives of EV-mediated mitochondrial therapy in MS. Graphical Abstract Schematic illustration showing the dual role of neuronal–microglial interaction under pathological and therapeutic conditions. (Left) Neuronal injury caused by oxidative stress, reduced ATP production, and reactive oxygen species (ROS) results in mitochondrial damage and the release of mtDNA, which is taken up by microglia, leading to microglial activation and neuroinflammation. (Right) Under therapeutic conditions, extracellular vesicle (EV)-mediated transfer of mitochondrial components or protective factors restores mitochondrial function, reduces neuroinflammation, and promotes neuronal recovery

1 February 2024 in Journal of Translational Medical Research
Verified
Journal Article
Open access
PDF file
FFFaezeh Fazlpour
Faezeh Fazlpour
NENafiseh Erfanian
Nafiseh Erfanian
SASayyedeh Fatemeh Askari
Sayyedeh Fatemeh Askari
HSHossein Safarpour
Hossein Safarpour
SNSaeed Nasseri
Saeed Nasseri
Background and Aims: Asthma is a chronic inflammatory disease of the airways, and its prevalence has been rapidly increasing worldwide over the past few decades. This research investigated the protective properties of the hydroalcoholic extract of Lavandula stoechas (L. stoechas) on blood cells through intraperitoneal and intranasal administration of ovalbumin in ...